Elisabeth Prevete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elisabeth Prevete has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Ornella Corazza
Department of Psychology and Cognitive Science, University of Trento, Rovereto, Italy
7 shared publications - Kim Paula Colette Kuypers
Department of Neuropsychology & Psychopharmacology, Faculty of Psychology & Neuroscience, Maastricht University, Maastricht, The Netherlands
4 shared publications - Francesco Saverio Bersani
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy
3 shared publications - Giuseppe Bersani
Department of Medico‐Surgical Sciences and Biotechnologies Sapienza University of Rome Rome Italy
3 shared publications Johannes G. Ramaekers
3 shared publicationsDarshan Singh
Universiti Sains Malaysia
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Elsevier in Emerging Trends in Drugs, Addictions, and Health
- Vol. 6
Emerging poisoning trends on social media: Sodium nitrite and nitrate content on TikTok
- 28 October 2026
- Published by Elsevier in Emerging Trends in Drugs, Addictions, and Health
- Vol. 6
Open AccessEmerging poisoning trends on social media: Sodium nitrite and nitrate content on TikTok
- Open Access
- 30 September 2025
- Published by Akademiai Kiado Zrt. in Journal of Behavioral Addictions
- Vol. 14 (3) , 1159-1198
Forms of interventions for problematic usage of the internet: A scoping review
Background and aims: This scoping review aims to identify current forms of interventions for Problematic Usage of the Internet (PUI) to inform more effective intervention and policy-making initiatives grounded in robust empirical evidence. Methods: The search was conducted in the PubMed, Scopus, and PsycINFO databases until October 12, 2024. Empirical research presenting data on interventions for PUI and written in English was included without restrictions of age groups, types of interventions, or types of PUI. Results: Five main forms of interventions for PUI were identified in the 77 studies included in the review, namely, pharmacotherapy, transcranial direct current stimulation, physical exercise, electroacupuncture, and psychotherapy or educational programs. Most studies were conducted in Asian and Middle-Eastern countries, and various validated instruments were used to assess PUI. Psychotherapy and education were the most common interventions in research. Apart from time spent online, positive results of the various interventions were reported on the respective PUI scales in most studies. However, studies with rigorous designs showed non-significant changes, suggesting that methodological differences may influence the reported outcomes. Discussion and conclusions: The different interventions reflect the multidimensional nature and complexity of PUI treatment and prevention strategies. Although current interventions show potential, more robust and rigorous study designs are necessary to draw definite conclusions. Further investigation is needed to understand the influence of comorbidities and the impact of individuals actively seeking help on treatment outcomes. Additionally, more substantial evidence is required to evaluate the effectiveness of PUI prevention efforts, particularly considering varying levels of PUI severity.
- 30 September 2025
- Published by Akademiai Kiado Zrt. in Journal of Behavioral Addictions
- Vol. 14 (3) , 1159-1198
Open AccessForms of interventions for problematic usage of the internet: A scoping review
Background and aims: This scoping review aims to identify current forms of interventions for Problematic Usage of the Internet (PUI) to inform more effective intervention and policy-making initiatives grounded in robust empirical evidence. Methods: The search was conducted in the PubMed, Scopus, and PsycINFO databases until October 12, 2024. Empirical research presenting data on interventions for PUI and written in English was included without restrictions of age groups, types of interventions, or types of PUI. Results: Five main forms of interventions for PUI were identified in the 77 studies included in the review, namely, pharmacotherapy, transcranial direct current stimulation, physical exercise, electroacupuncture, and psychotherapy or educational programs. Most studies were conducted in Asian and Middle-Eastern countries, and various validated instruments were used to assess PUI. Psychotherapy and education were the most common interventions in research. Apart from time spent online, positive results of the various interventions were reported on the respective PUI scales in most studies. However, studies with rigorous designs showed non-significant changes, suggesting that methodological differences may influence the reported outcomes. Discussion and conclusions: The different interventions reflect the multidimensional nature and complexity of PUI treatment and prevention strategies. Although current interventions show potential, more robust and rigorous study designs are necessary to draw definite conclusions. Further investigation is needed to understand the influence of comorbidities and the impact of individuals actively seeking help on treatment outcomes. Additionally, more substantial evidence is required to evaluate the effectiveness of PUI prevention efforts, particularly considering varying levels of PUI severity.
- Open Access
- 13 December 2024
- Published by Elsevier in Emerging Trends in Drugs, Addictions, and Health
- Vol. 5
Use patterns of classic, novel, and herbal opioids
- 13 December 2024
- Published by Elsevier in Emerging Trends in Drugs, Addictions, and Health
- Vol. 5
Open AccessUse patterns of classic, novel, and herbal opioids
- 20 February 2024
- Published by Springer Nature
- p. 1097-1108
Schizophrenia and Other Late-Life Psychoses
- 1 December 2023
- Published by Springer Nature
- p. 1-12
Schizophrenia and Other Late-Life Psychoses
- 13 September 2023
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 56 (4) , 485-495
A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets
In recent years, the online sale of kratom (Mitragyna speciosa), a Southeast Asian plant with both medicinal and psychoactive properties, has raised health concerns mainly due to the uncontrolled diffusion of adulterated kratom-related products. This exploratory study provides, for the first time, a snapshot of the availability of kratom products on the darknet which has been further validated by data searches on the surface web. A total of 231 listings of kratom across 23 darknet marketplaces were identified between March 2020 and October 2021. Among these, 40 were found actively sold across five markets by thirteen vendors. Listed items were mainly advertised as "safe" substitutes for medicinal products for the self-management of pain and other health conditions and offered in various forms (e.g., dry leaf powder, pills, capsules). Purchases were made using cryptocurrencies, with some vendors offering Pretty Good Privacy, and were shipped from Europe, Australia, the United States, and the United Kingdom. Goods sold by the same sellers also included illicit drugs and fraud-related products. Our study discovered a previously unknown diffusion of kratom products on the darknet mainly for self-treating a variety of medical conditions, suggesting the need for further research and immediate interventions to safeguard the well-being and health of kratom consumers.
- 13 September 2023
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 56 (4) , 485-495
A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets
In recent years, the online sale of kratom (Mitragyna speciosa), a Southeast Asian plant with both medicinal and psychoactive properties, has raised health concerns mainly due to the uncontrolled diffusion of adulterated kratom-related products. This exploratory study provides, for the first time, a snapshot of the availability of kratom products on the darknet which has been further validated by data searches on the surface web. A total of 231 listings of kratom across 23 darknet marketplaces were identified between March 2020 and October 2021. Among these, 40 were found actively sold across five markets by thirteen vendors. Listed items were mainly advertised as "safe" substitutes for medicinal products for the self-management of pain and other health conditions and offered in various forms (e.g., dry leaf powder, pills, capsules). Purchases were made using cryptocurrencies, with some vendors offering Pretty Good Privacy, and were shipped from Europe, Australia, the United States, and the United Kingdom. Goods sold by the same sellers also included illicit drugs and fraud-related products. Our study discovered a previously unknown diffusion of kratom products on the darknet mainly for self-treating a variety of medical conditions, suggesting the need for further research and immediate interventions to safeguard the well-being and health of kratom consumers.
- Open Access
- 12 May 2023
- Published by Springer Nature in Current Addiction Reports
- Vol. 10 (2) , 317-334
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
: Purpose of Review: This work aims to provide an up-to-date review of the preclinical and clinical scientific literature on the therapeutic value of kratom to better understand the underlying mechanisms related to its use and inform future therapeutic applications.Recent Findings: A growing number of studies, mainly of cross-sectional nature, describe the widespread use of kratom by individuals to self-treat pain, psychiatric symptoms, and substance use disorders (SUD) outside a controlled clinical setting. Preclinical evidence suggests kratom is effective as an analgesic agent and might decrease the self-administration of other drugs. A randomized controlled trial has further supported kratom’s therapeutic value as an analgesic. Investigations in nonclinical samples of long-term kratom users also indicate its therapeutic benefit in managing SUD symptoms (e.g., craving) and long-term or acute symptoms (e.g., withdrawal) for alcohol, opioids, and other illicit drugs. However, episodes of kratom-related intoxications have also been reported, often due to the adulteration and the contamination of kratom products mainly sold online or mixed toxicities when consumed outside clinical and traditional settings.Summary: Evidence on the clinical implications of kratom use is still limited and uncertain, with kratom research constantly evolving. Therefore, further randomized trials are needed.
- 12 May 2023
- Published by Springer Nature in Current Addiction Reports
- Vol. 10 (2) , 317-334
Open AccessClinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
: Purpose of Review: This work aims to provide an up-to-date review of the preclinical and clinical scientific literature on the therapeutic value of kratom to better understand the underlying mechanisms related to its use and inform future therapeutic applications.Recent Findings: A growing number of studies, mainly of cross-sectional nature, describe the widespread use of kratom by individuals to self-treat pain, psychiatric symptoms, and substance use disorders (SUD) outside a controlled clinical setting. Preclinical evidence suggests kratom is effective as an analgesic agent and might decrease the self-administration of other drugs. A randomized controlled trial has further supported kratom’s therapeutic value as an analgesic. Investigations in nonclinical samples of long-term kratom users also indicate its therapeutic benefit in managing SUD symptoms (e.g., craving) and long-term or acute symptoms (e.g., withdrawal) for alcohol, opioids, and other illicit drugs. However, episodes of kratom-related intoxications have also been reported, often due to the adulteration and the contamination of kratom products mainly sold online or mixed toxicities when consumed outside clinical and traditional settings.Summary: Evidence on the clinical implications of kratom use is still limited and uncertain, with kratom research constantly evolving. Therefore, further randomized trials are needed.
- Open Access
- 20 May 2022
- Published by MDPI AG in Healthcare
- Vol. 10 (5) , 948
Problematic Use of the Internet Mediates the Association between Reduced Mentalization and Suicidal Ideation: A Cross-Sectional Study in Young Adults
Suicide is a major public health problem, and it is urgent to investigate its underlying clinical and psychological concomitants. It has been suggested that low mentalization skills and problematic use of the internet (PUI) are factors that can play a role in suicidal behaviors. It is possible that poor mentalization skills contribute to leading to forms of PUI, which, in turn, can represent triggers for suicidal ideation (SI). We tested this hypothesis through a quantitative and cross-sectional study on a sample (n = 623) of young adults (age range: 18–34). Self-report measures investigating symptoms related to Social Media Addiction (SMA), Internet Gaming Disorder (IGD), mentalization capacity, and SI were used. A single mediation analysis with two mediators was carried out to evaluate the direct and indirect effects of mentalization on SI through the mediating role of SMA- and IGD-related symptoms, controlling for potential confounding factors (e.g., socio-demographic and addiction-related variables). The four explored variables were significantly associated with each other (all p < 0.001) across all subjects; the mediational model showed that the total effect of mentalization on SI was significant (B = −0.821, SE = 0.092 (95% CI: −1.001; −0.641)) and that both SMA- (B = −0.073, SE = 0.034 (95% CI: −0.145; −0.008)) and IGD-related symptoms (B = 0.046, SE = 0.027 (95% CI: −0.107; −0.001)) were significant mediators of such association. Our findings support the possibility that PUI severity plays a relevant role in mediating the association between low mentalization skills and levels of SI.
- 20 May 2022
- Published by MDPI AG in Healthcare
- Vol. 10 (5) , 948
Open AccessProblematic Use of the Internet Mediates the Association between Reduced Mentalization and Suicidal Ideation: A Cross-Sectional Study in Young Adults
Suicide is a major public health problem, and it is urgent to investigate its underlying clinical and psychological concomitants. It has been suggested that low mentalization skills and problematic use of the internet (PUI) are factors that can play a role in suicidal behaviors. It is possible that poor mentalization skills contribute to leading to forms of PUI, which, in turn, can represent triggers for suicidal ideation (SI). We tested this hypothesis through a quantitative and cross-sectional study on a sample (n = 623) of young adults (age range: 18–34). Self-report measures investigating symptoms related to Social Media Addiction (SMA), Internet Gaming Disorder (IGD), mentalization capacity, and SI were used. A single mediation analysis with two mediators was carried out to evaluate the direct and indirect effects of mentalization on SI through the mediating role of SMA- and IGD-related symptoms, controlling for potential confounding factors (e.g., socio-demographic and addiction-related variables). The four explored variables were significantly associated with each other (all p < 0.001) across all subjects; the mediational model showed that the total effect of mentalization on SI was significant (B = −0.821, SE = 0.092 (95% CI: −1.001; −0.641)) and that both SMA- (B = −0.073, SE = 0.034 (95% CI: −0.145; −0.008)) and IGD-related symptoms (B = 0.046, SE = 0.027 (95% CI: −0.107; −0.001)) were significant mediators of such association. Our findings support the possibility that PUI severity plays a relevant role in mediating the association between low mentalization skills and levels of SI.
- Open Access
- 4 May 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (7) , e15533
A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
- 4 May 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (7) , e15533
Open AccessA case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
- Open Access
- 26 July 2021
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 37 (1) , e2805
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Introduction: Kratom (Mitragyna speciosa) is a tropical plant traditionally used as an ethnomedicinal remedy for several conditions in South East Asia. Despite the increased interest in its therapeutical benefits in Western countries, little scientific evidence is available to support such claims, and existing data remain limited to kratom's chronic consumption.Objective: Our study aims to investigate (pre)clinical evidence on the efficacy of kratom as a therapeutic aid and its safety profile in humans.Methods: A systematic literature search using PubMed and the Medline database was conducted between April and November 2020.Results: Both preclinical (N = 57) and clinical (N = 18) studies emerged from our search. Preclinical data indicated a therapeutic value in terms of acute/chronic pain (N = 23), morphine/ethanol withdrawal, and dependence (N = 14), among other medical conditions (N = 26). Clinical data included interventional studies (N = 2) reporting reduced pain sensitivity, and observational studies (N = 9) describing the association between kratom's chronic (daily/frequent) use and safety issues, in terms of health consequences (e.g., learning impairment, high cholesterol level, dependence/withdrawal).Conclusions: Although the initial (pre)clinical evidence on kratom's therapeutic potential and its safety profile in humans is encouraging, further validation in large, controlled clinical trials is required.
- 26 July 2021
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 37 (1) , e2805
Open AccessA systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Introduction: Kratom (Mitragyna speciosa) is a tropical plant traditionally used as an ethnomedicinal remedy for several conditions in South East Asia. Despite the increased interest in its therapeutical benefits in Western countries, little scientific evidence is available to support such claims, and existing data remain limited to kratom's chronic consumption.Objective: Our study aims to investigate (pre)clinical evidence on the efficacy of kratom as a therapeutic aid and its safety profile in humans.Methods: A systematic literature search using PubMed and the Medline database was conducted between April and November 2020.Results: Both preclinical (N = 57) and clinical (N = 18) studies emerged from our search. Preclinical data indicated a therapeutic value in terms of acute/chronic pain (N = 23), morphine/ethanol withdrawal, and dependence (N = 14), among other medical conditions (N = 26). Clinical data included interventional studies (N = 2) reporting reduced pain sensitivity, and observational studies (N = 9) describing the association between kratom's chronic (daily/frequent) use and safety issues, in terms of health consequences (e.g., learning impairment, high cholesterol level, dependence/withdrawal).Conclusions: Although the initial (pre)clinical evidence on kratom's therapeutic potential and its safety profile in humans is encouraging, further validation in large, controlled clinical trials is required.